Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Promega Corporation
Promega Corporation
Activities:
Manufacturing
Research & Development
Analysis
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
Researchers improve performance of targeted protein degradation
Targeted protein degradation involves co-opting a cell’s natural disposal systems to remove disease causing proteins
Ingredients
Promega launches XpressAmp Direct Amplification reagents
The reagents are designed to allow COVID-19 testing labs to skip the RNA extraction process
Media
Protein purification and isolation market worth US$6370m by 2020
The market is growing due to increased R&D, as well as demand for ligand ID and rapid purification kits
Regulatory
Promega and BASF develop alternative method for detecting allergenic substances
Using a newly developed cell line
Manufacturing
Promega opens new Shanghai facility
Provides additional r&d and cGMP manufacturing capabilities
Manufacturing
Promega builds plant to produce regulated products
Including sample preparation systems and reagents
Subscribe now